Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.44 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.39 |
| ▸ | ESR1 | P03372 | 1/20 | 0.38 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.38 |
| ▸ | PDK2 | Q15119 | 3/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | CFTR | P13569 | 1/20 | 0.34 |
| ▸ | GOPC | Q9HD26 | 1/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | KIF11 | P52732 | 1/20 | 0.33 |
| ▸ | PTPRC | P08575 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19009208 | 0.88 | KMT2A (0.41) | KMT2AMEN1LMNASMN1; SMN2KDM4E | |
| SCHEMBL30322773 | 0.88 | KMT2A (0.41) | KMT2AMEN1LMNASMN1; SMN2KDM4E | |
| SCHEMBL19886866 | 0.83 | PDK2 (0.38) | KMT2AMEN1LMNASMN1; SMN2KDM4E | |
| SCHEMBL21104282 | 0.80 | PDK2 (0.39) | KMT2AMEN1LMNASMN1; SMN2KDM4E | |
| SCHEMBL18174536 | 0.78 | PDK2 (0.51) | KMT2AMEN1LMNASMN1; SMN2KDM4E | |
| SCHEMBL13009940 | 0.78 | MEN1 (0.44) | KMT2AMEN1LMNASMN1; SMN2KDM4E | |
| SCHEMBL22085469 | 0.77 | ALDH1A1 (0.38) | KMT2AMEN1LMNASMN1; SMN2KDM4E | |
| SCHEMBL20938307 | 0.77 | PDK2 (0.34) | KMT2AMEN1LMNASMN1; SMN2KDM4E | |
| SCHEMBL22100048 | 0.77 | MEN1 (0.41) | KMT2AMEN1LMNASMN1; SMN2KDM4E | |
| SCHEMBL129053 | 0.77 | MEN1 (0.67) | KMT2AMEN1LMNASMN1; SMN2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023179094-A1 | ORGANIC COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE COMPRISING SAME | 北京莱特众成光电材料科技有限公司 | 2023-09-28 | — | — | WO | disclosed |
| EP-3127987-B1 | ORGANIC LIGHT-EMITTING DEVICE | LG CHEMICAL LTD (KR) | 2018-03-14 | — | — | EP | disclosed |
| EP-3127987-A1 | ORGANIC LIGHT-EMITTING DEVICE | LG Chem, Ltd. (KR) | 2017-02-08 | — | — | EP | disclosed |
| US-20160329509-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION | 2016-11-10 | — | — | US | disclosed |
| US-20160329509-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION | 2016-11-10 | — | — | US | disclosed |
| US-9478758-B1 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2016-10-25 | — | — | US | disclosed |
| US-9478758-B1 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2016-10-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160329509-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | SOD1, SLC25A21, SLC25A11 | KMT2A 3230/4885MEN1 1341/4885LMNA 3860/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.